For the quarter ending 2026-03-31, APTN has $706,117 in assets. $2,481,688 in debts. $301,309 in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 301,309 | 459,174 | ||
| Prepaid expenses and other current assets | - | 159,985 | ||
| Prepaid expenses | 404,808 | - | ||
| Total current assets | 706,117 | 619,159 | ||
| Total assets | 706,117 | 619,159 | ||
| Accounts payable- trade | 1,371,309 | 1,512,090 | ||
| Accrued expenses | 869,681 | 596,465 | ||
| Financing liability | 240,698 | - | ||
| Total current liabilities | 2,481,688 | 2,108,555 | ||
| Total liabilities | 2,481,688 | 2,108,555 | ||
| Common stock, 0.0001 par value, 50,000,000 shares authorized, 8,786,229 shares issued and outstanding as of march 31, 2026 and 8,655,829 shares issued and outstanding as of december 31, 2025 | 879 | 866 | ||
| Additional paid-in capital | 8,661,447 | 7,801,539 | ||
| Accumulated deficit | -10,437,897 | -9,291,801 | ||
| Total stockholders deficit | -1,775,571 | -1,489,396 | ||
| Total liabilities and stockholders deficit | 706,117 | 619,159 | ||
ADAPTIN BIO, INC. (APTN)
ADAPTIN BIO, INC. (APTN)